Comments
Lupin has launched generic Abacavir and Lamivudine tablets used for the treatment of human immunodeficiency infection in the American market.
The company had earlier received approval from the United States Food and Drug Administration (USFDA) for Abacavir and Lamivudine tablets 600 mg/300 mg, Lupin said in a statement.
Lupin’s tablets are generic versions of ViiV Healthcare Company’s Epzicom tablets in the same strength, it added.
The product is “indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection,” Lupin said.
Epzicom tablets had US sales of $388.1 million as per IMS MAT December 2016 data, it added.
The company’s cumulative filings with the USFDA now stand at 349, with 213 products already approved, Lupin said.
Shares of Lupin Ltd were trading at Rs 1,455, down 0.10 per cent from its previous close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.